Policy Changes: Treatment

Transition to TLD: Support national ART guidance revision to reflect the current WHO guidelines for rapid and safe transition to TLD regimen; transition completely out of Nevirapine-based regimen for all adults.


Male viral load suppression increased throughout the year from 53% to as high as 96% after DTG transition as compared to 46% to 94% before DTG use.


This facility started with 4% of patients on TLD, but ended the year with nearly 30% on TLD.

Patients on TLD were significantly more likely to be virally suppressed and less likely to be LTFU.